280 related articles for article (PubMed ID: 12441685)
1. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.
Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson NS
J Vet Sci; 2001 Dec; 2(3):167-79. PubMed ID: 12441685
[TBL] [Abstract][Full Text] [Related]
2. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
3. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.
Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A
Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626
[TBL] [Abstract][Full Text] [Related]
4. Self-renewal of murine embryonic stem cells is supported by the serine/threonine kinases Pim-1 and Pim-3.
Aksoy I; Sakabedoyan C; Bourillot PY; Malashicheva AB; Mancip J; Knoblauch K; Afanassieff M; Savatier P
Stem Cells; 2007 Dec; 25(12):2996-3004. PubMed ID: 17717068
[TBL] [Abstract][Full Text] [Related]
5. [The Pim family of protein kinases: structure, functions and roles in hematopoietic malignancies].
Zhukova IuN; Alekseeva MG; Zakharevich NV; Shtil' AA; Danilenko VN
Mol Biol (Mosk); 2011; 45(5):755-64. PubMed ID: 22393773
[TBL] [Abstract][Full Text] [Related]
6. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
[TBL] [Abstract][Full Text] [Related]
7. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
Mikkers H; Nawijn M; Allen J; Brouwers C; Verhoeven E; Jonkers J; Berns A
Mol Cell Biol; 2004 Jul; 24(13):6104-15. PubMed ID: 15199164
[TBL] [Abstract][Full Text] [Related]
8. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
[TBL] [Abstract][Full Text] [Related]
9. Roles of Pim-3, a novel survival kinase, in tumorigenesis.
Mukaida N; Wang YY; Li YY
Cancer Sci; 2011 Aug; 102(8):1437-42. PubMed ID: 21518143
[TBL] [Abstract][Full Text] [Related]
10. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
Gong J; Wang J; Ren K; Liu C; Li B; Shi Y
J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992
[TBL] [Abstract][Full Text] [Related]
11. The serine/threonine kinase Pim-1.
Bachmann M; Möröy T
Int J Biochem Cell Biol; 2005 Apr; 37(4):726-30. PubMed ID: 15694833
[TBL] [Abstract][Full Text] [Related]
12. Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation.
Mochizuki T; Kitanaka C; Noguchi K; Sugiyama A; Kagaya S; Chi S; Asai A; Kuchino Y
Oncogene; 1997 Sep; 15(12):1471-80. PubMed ID: 9333023
[TBL] [Abstract][Full Text] [Related]
13. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.
Slupianek A; Nieborowska-Skorska M; Hoser G; Morrione A; Majewski M; Xue L; Morris SW; Wasik MA; Skorski T
Cancer Res; 2001 Mar; 61(5):2194-9. PubMed ID: 11280786
[TBL] [Abstract][Full Text] [Related]
14. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related.
Lilly M; Le T; Holland P; Hendrickson SL
Oncogene; 1992 Apr; 7(4):727-32. PubMed ID: 1314369
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Pim-1 by Hsp90.
Mizuno K; Shirogane T; Shinohara A; Iwamatsu A; Hibi M; Hirano T
Biochem Biophys Res Commun; 2001 Mar; 281(3):663-9. PubMed ID: 11237709
[TBL] [Abstract][Full Text] [Related]
16. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
[TBL] [Abstract][Full Text] [Related]
17. Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells.
Lilly M; Kraft A
Cancer Res; 1997 Dec; 57(23):5348-55. PubMed ID: 9393759
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1.
Liang H; Hittelman W; Nagarajan L
Arch Biochem Biophys; 1996 Jun; 330(2):259-65. PubMed ID: 8660654
[TBL] [Abstract][Full Text] [Related]
19. [Apoptosis related gene, Pim-1].
Ariga H; Iguchi-Ariga SM
Nihon Rinsho; 1996 Jul; 54(7):1903-6. PubMed ID: 8741685
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]